Remove Biotechnology Remove Efficiency Remove Talent
article thumbnail

The Promise and Challenge of Big Data for Pharma

Harvard Business

For the industry, the biggest challenge by far has been talent: upgrading skill sets from those sufficient to analyze relatively small amounts of clinical trial data to those required to gain insights from the vast amount of real-world data, including unstructured data such as physicians’ notes, scans and images, and pathology reports.

Data 70
article thumbnail

Beyond the Rhetoric: The Future for Biotech & Health Policy

Tom Spencer

As we stand on the cusp of a political shift in the United States, the intersection of biotechnology, regulatory policy, and healthcare is poised for profound transformation. If policies support research, development, and efficient approval processes, the biotech sector could thrive even amidst political turbulence.